Insider Selling: STERIS (STE) VP Sells $192,374.91 in Stock

STERIS (NYSE:STE) VP Sudhir K. Pahwa sold 1,981 shares of the company’s stock in a transaction on Wednesday, April 18th. The stock was sold at an average price of $97.11, for a total value of $192,374.91. The sale was disclosed in a filing with the SEC, which is available at this link.

Sudhir K. Pahwa also recently made the following trade(s):

How to Become a New Pot Stock Millionaire
  • On Monday, January 29th, Sudhir K. Pahwa sold 2,000 shares of STERIS stock. The stock was sold at an average price of $92.09, for a total value of $184,180.00.

STE stock opened at $96.04 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.22 and a current ratio of 2.82. STERIS has a 1-year low of $70.29 and a 1-year high of $97.47. The firm has a market capitalization of $8,164.08, a price-to-earnings ratio of 25.54 and a beta of 1.12.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.05. STERIS had a return on equity of 11.57% and a net margin of 9.42%. The business had revenue of $661.90 million for the quarter, compared to analysts’ expectations of $663.17 million. During the same quarter in the previous year, the firm earned $0.98 earnings per share. The business’s revenue was up 2.3% on a year-over-year basis. research analysts predict that STERIS will post 4.13 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 28th. Stockholders of record on Wednesday, February 28th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date was Tuesday, February 27th. This is a boost from STERIS’s previous quarterly dividend of $0.21. STERIS’s dividend payout ratio is currently 32.98%.

Several hedge funds and other institutional investors have recently modified their holdings of STE. Captrust Financial Advisors purchased a new position in shares of STERIS during the 4th quarter valued at $101,000. Meeder Asset Management Inc. lifted its position in shares of STERIS by 1,122.4% during the 4th quarter. Meeder Asset Management Inc. now owns 1,198 shares of the medical equipment provider’s stock valued at $104,000 after buying an additional 1,100 shares during the last quarter. YorkBridge Wealth Partners LLC purchased a new position in shares of STERIS during the 4th quarter valued at $113,000. Driehaus Capital Management LLC purchased a new position in shares of STERIS during the 4th quarter valued at $241,000. Finally, QS Investors LLC lifted its position in shares of STERIS by 36,250.0% during the 4th quarter. QS Investors LLC now owns 2,908 shares of the medical equipment provider’s stock valued at $254,000 after buying an additional 2,900 shares during the last quarter. 89.37% of the stock is currently owned by hedge funds and other institutional investors.

STE has been the topic of several research analyst reports. Zacks Investment Research cut STERIS from a “buy” rating to a “hold” rating in a research report on Wednesday, March 28th. Northcoast Research set a $102.00 price objective on STERIS and gave the stock a “buy” rating in a research report on Thursday, February 8th. KeyCorp reissued a “buy” rating and issued a $103.00 price objective on shares of STERIS in a research report on Thursday, February 8th. Finally, Raymond James reissued a “market perform” rating and issued a $100.00 price objective on shares of STERIS in a research report on Wednesday, January 3rd. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $85.40.

TRADEMARK VIOLATION NOTICE: “Insider Selling: STERIS (STE) VP Sells $192,374.91 in Stock” was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://www.thelincolnianonline.com/2018/04/22/insider-selling-steris-ste-vp-sells-192374-91-in-stock.html.

About STERIS

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.

Insider Buying and Selling by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply